Sulfonilurea (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Sulfonilurea" in Galician language version.

Last modified: 20:19:06, 4 July 2026 (UTC)

Ref.Un. Ref.Website

Global rank Galician rank

3225nih.gov

5^th place

2^nd place

2922doi.org

2^nd place

3^rd place

44archive.org

6^th place

4^th place

33adsabs.harvard.edu

14^th place

17^th place

22worldcat.org

4^th place

7^th place

21web.archive.org

1^st place

21fda.gov

470^th place

343^rd place

11orst.edu

low place

2,626^th place

11weedscience.org

low place

11aesacademy.org

low place

11retractionwatch.com

low place

11books.google.com

3^rd place

11^th place

11hdl.handle.net

66^th place

88^th place

adsabs.harvard.edu (Global: 14^th place; Galician: 17^th place)

Duggleby RG, McCourt JA, Guddat LW (marzo de 2008). "Structure and mechanism of inhibition of plant acetohydroxyacid synthase". Plant Physiology and Biochemistry 46 (3): 309–324. Bibcode:2008PlPB...46..309D. PMID 18234503. doi:10.1016/j.plaphy.2007.12.004.
Lamberth C, Jeanmart S, Luksch T, Plant A (agosto de 2013). "Current challenges and trends in the discovery of agrochemicals". Science 341 (6147): 742–6. Bibcode:2013Sci...341..742L. PMID 23950530. doi:10.1126/science.1237227.
Zhang CL, Katoh M, Shibasaki T, Minami K, Sunaga Y, Takahashi H, et al. (xullo de 2009). "The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs". Science 325 (5940): 607–610. Bibcode:2009Sci...325..607Z. PMID 19644119. doi:10.1126/science.1172256.

aesacademy.org (Global: low place; Galician: low place)

"Pesticides in agriculture and environment: Impacts on human health" (PDF). aesacademy.org.

archive.org (Global: 6^th place; Galician: 4^th place)

Lamberth C, Jeanmart S, Luksch T, Plant A (agosto de 2013). "Current challenges and trends in the discovery of agrochemicals". Science 341 (6147): 742–6. Bibcode:2013Sci...341..742L. PMID 23950530. doi:10.1126/science.1237227.
Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. (xaneiro de 2009). "Glucose control and vascular complications in veterans with type 2 diabetes". The New England Journal of Medicine 360 (2): 129–139. PMID 19092145. doi:10.1056/NEJMoa0808431.
Zhang CL, Katoh M, Shibasaki T, Minami K, Sunaga Y, Takahashi H, et al. (xullo de 2009). "The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs". Science 325 (5940): 607–610. Bibcode:2009Sci...325..607Z. PMID 19644119. doi:10.1126/science.1172256.
Patlak M (decembro de 2002). "New weapons to combat an ancient disease: treating diabetes". FASEB Journal 16 (14): 1853. PMID 12468446. doi:10.1096/fj.02-0974bkt.

books.google.com (Global: 3^rd place; Galician: 11^th place)

Davidson J (2000). Clinical diabetes mellitus: a problem-oriented approach. Stuttgart: Thieme. p. 422. ISBN 978-0-86577-840-5.

doi.org (Global: 2^nd place; Galician: 3^rd place)

dx.doi.org

Duggleby RG, McCourt JA, Guddat LW (marzo de 2008). "Structure and mechanism of inhibition of plant acetohydroxyacid synthase". Plant Physiology and Biochemistry 46 (3): 309–324. Bibcode:2008PlPB...46..309D. PMID 18234503. doi:10.1016/j.plaphy.2007.12.004.
Arnold P. Appleby, Franz Müller, Serge Carpy "Weed Control" in Ullmann's Encyclopedia of Industrial Chemistry 2002, Wiley-VCH, Weinheim. doi 10.1002/14356007.a28_165
Lamberth C, Jeanmart S, Luksch T, Plant A (agosto de 2013). "Current challenges and trends in the discovery of agrochemicals". Science 341 (6147): 742–6. Bibcode:2013Sci...341..742L. PMID 23950530. doi:10.1126/science.1237227.
Seino S (de agosto de 2012). "Cell signalling in insulin secretion: the molecular targets of ATP, cAMP and sulfonylurea". Diabetologia 55 (8): 2096–2108. PMID 22555472. doi:10.1007/s00125-012-2562-9.
Greeley SA, Tucker SE, Naylor RN, Bell GI, Philipson LH (agosto de 2010). "Neonatal diabetes mellitus: a model for personalized medicine". Trends in Endocrinology and Metabolism 21 (8): 464–472. PMC 2914172. PMID 20434356. doi:10.1016/j.tem.2010.03.004.
Brophy S, Davies H, Mannan S, Brunt H, Williams R (setembro de 2011). "Interventions for latent autoimmune diabetes (LADA) in adults". The Cochrane Database of Systematic Reviews 2011 (9 (número de artigo: CD006165)). PMC 6486159. PMID 21901702. doi:10.1002/14651858.cd006165.pub3.
Rados DV, Pinto LC, Remonti LR, Leitão CB, Gross JL (xuño de 2016). "Correction: The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials". PLOS Medicine 13 (6 (número de artigo: e1002091)). PMC 4920361. PMID 27340828. doi:10.1371/journal.pmed.1002091.
Gnesin F, Thuesen AC, Kähler LK, Madsbad S, Hemmingsen B (xuño de 2020). "Metformin monotherapy for adults with type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews 2020 (6 (número de artigo: CD012906)). PMC 7386876. PMID 32501595. doi:10.1002/14651858.CD012906.pub2. (colaboración: Cochrane Metabolic and Endocrine Disorders Group)
Madsen KS, Chi Y, Metzendorf MI, Richter B, Hemmingsen B (decembro de 2019). "Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews 2019 (12 (número de artigo: CD008558)). PMC 6889926. PMID 31794067. doi:10.1002/14651858.CD008558.pub2. (colaboración: Cochrane Metabolic and Endocrine Disorders Group)
Madsen KS, Kähler P, Kähler LK, Madsbad S, Gnesin F, Metzendorf MI, et al. (abril de 2019). Cochrane Metabolic and Endocrine Disorders Group, ed. "Metformin and second- or third-generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews 4 (4 (número de artigo: CD012368)). PMC 6472662. PMID 30998259. doi:10.1002/14651858.CD012368.pub2.
Kulkarni, Amol A.; Sajith, Ayyiliath M.; Duarte, Trevor T.; Tena, Anahis; Spencer, Charles T.; Bowen, J. Phillip (2020). "Design, synthesis, and screening of sulfonylurea-derived NLRP3 inflammasome inhibitors". Medicinal Chemistry Research 29 (1): 126–135. ISSN 1054-2523. PMC 7223447. PMID 32435125. doi:10.1007/s00044-019-02466-7.
Coll RC, Robertson AA, Chae JJ, Higgins SC, Muñoz-Planillo R, Inserra MC, et al. (marzo de 2015). "A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases". Nature Medicine 21 (3): 248–255. PMC 4392179. PMID 25686105. doi:10.1038/nm.3806.
Shyangdan DS, Royle P, Clar C, Sharma P, Waugh N, Snaith A (outubro de 2011). "Glucagon-like peptide analogues for type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews 2011 (10 (número de artigo: CD006423)). PMC 6486297. PMID 21975753. doi:10.1002/14651858.cd006423.pub2.
Hemmingsen B, Schroll JB, Wetterslev J, Gluud C, Vaag A, Sonne DP, et al. (xullo de 2014). "Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysis". CMAJ Open 2 (3): E162–E175. PMC 4185978. PMID 25295236. doi:10.9778/cmajo.20130073.
Hemmingsen B, Schroll JB, Lund SS, Wetterslev J, Gluud C, Vaag A, et al. (abril de 2013). Hemmingsen B, ed. "Sulphonylurea monotherapy for patients with type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews 4 (4 (número de artigo: CD009008)). PMID 23633364. doi:10.1002/14651858.CD009008.pub2. Retractado doi 10.1002/14651858.CD009008.pub3 PMID 26222249 Retraction Watch
Gerstein HC, Miller ME, Byington RP, Goff DC, Bigger JT, Buse JB, et al. (xuño de 2008). "Effects of intensive glucose lowering in type 2 diabetes". The New England Journal of Medicine 358 (24): 2545–2559. PMC 4551392. PMID 18539917. doi:10.1056/NEJMoa0802743.
Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. (xaneiro de 2009). "Glucose control and vascular complications in veterans with type 2 diabetes". The New England Journal of Medicine 360 (2): 129–139. PMID 19092145. doi:10.1056/NEJMoa0808431.
Proks P, Reimann F, Green N, Gribble F, Ashcroft F (decembro de 2002). "Sulfonylurea stimulation of insulin secretion". Diabetes 51 (Suppl 3): S368–S376. PMID 12475777. doi:10.2337/diabetes.51.2007.S368.
Yu, Ming; Feng, Xiao-Yu; Yao, Shuai; Wang, Chang; Yang, Ping (2022-09-16). "Certain sulfonylurea drugs increase serum free fatty acid in diabetic patients: A systematic review and meta-analysis". World Journal of Clinical Cases 10 (26): 9524–9535. ISSN 2307-8960. PMC 9477688. PMID 36159441. doi:10.12998/wjcc.v10.i26.9524.
Zhang CL, Katoh M, Shibasaki T, Minami K, Sunaga Y, Takahashi H, et al. (xullo de 2009). "The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs". Science 325 (5940): 607–610. Bibcode:2009Sci...325..607Z. PMID 19644119. doi:10.1126/science.1172256.
Takahashi T, Shibasaki T, Takahashi H, Sugawara K, Ono A, Inoue N, et al. (outubro de 2013). "Antidiabetic sulfonylureas and cAMP cooperatively activate Epac2A". Science Signaling 6 (298): ra94. PMID 24150255. doi:10.1126/scisignal.2004581. hdl:20.500.14094/D1005987.
Patlak M (decembro de 2002). "New weapons to combat an ancient disease: treating diabetes". FASEB Journal 16 (14): 1853. PMID 12468446. doi:10.1096/fj.02-0974bkt.

fda.gov (Global: 470^th place; Galician: 343^rd place)

accessdata.fda.gov

"Diaßeta (glyburide) Tablets USP" (PDF). Sanofi-Aventis U.S. LLC. U.S. Food and Drug Administration. 2009. Arquivado dende o orixinal (PDF) o 2 de xaneiro de 2015.

hdl.handle.net (Global: 66^th place; Galician: 88^th place)

Takahashi T, Shibasaki T, Takahashi H, Sugawara K, Ono A, Inoue N, et al. (outubro de 2013). "Antidiabetic sulfonylureas and cAMP cooperatively activate Epac2A". Science Signaling 6 (298): ra94. PMID 24150255. doi:10.1126/scisignal.2004581. hdl:20.500.14094/D1005987.

nih.gov (Global: 5^th place; Galician: 2^nd place)

ncbi.nlm.nih.gov

Costello, Ryan A.; Nicolas, Samar; Shivkumar, Abhijit (2024). Sulfonylureas. StatPearls (Treasure Island (FL): StatPearls Publishing). PMID 30020597. Consultado o 2024-08-01.
Duggleby RG, McCourt JA, Guddat LW (marzo de 2008). "Structure and mechanism of inhibition of plant acetohydroxyacid synthase". Plant Physiology and Biochemistry 46 (3): 309–324. Bibcode:2008PlPB...46..309D. PMID 18234503. doi:10.1016/j.plaphy.2007.12.004.
Lamberth C, Jeanmart S, Luksch T, Plant A (agosto de 2013). "Current challenges and trends in the discovery of agrochemicals". Science 341 (6147): 742–6. Bibcode:2013Sci...341..742L. PMID 23950530. doi:10.1126/science.1237227.
Seino S (de agosto de 2012). "Cell signalling in insulin secretion: the molecular targets of ATP, cAMP and sulfonylurea". Diabetologia 55 (8): 2096–2108. PMID 22555472. doi:10.1007/s00125-012-2562-9.
Sulfonylureas. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury (Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases). 2012. PMID 31643682. Consultado o 2024-08-01.
Greeley SA, Tucker SE, Naylor RN, Bell GI, Philipson LH (agosto de 2010). "Neonatal diabetes mellitus: a model for personalized medicine". Trends in Endocrinology and Metabolism 21 (8): 464–472. PMC 2914172. PMID 20434356. doi:10.1016/j.tem.2010.03.004.
Brophy S, Davies H, Mannan S, Brunt H, Williams R (setembro de 2011). "Interventions for latent autoimmune diabetes (LADA) in adults". The Cochrane Database of Systematic Reviews 2011 (9 (número de artigo: CD006165)). PMC 6486159. PMID 21901702. doi:10.1002/14651858.cd006165.pub3.
Rados DV, Pinto LC, Remonti LR, Leitão CB, Gross JL (xuño de 2016). "Correction: The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials". PLOS Medicine 13 (6 (número de artigo: e1002091)). PMC 4920361. PMID 27340828. doi:10.1371/journal.pmed.1002091.
Gnesin F, Thuesen AC, Kähler LK, Madsbad S, Hemmingsen B (xuño de 2020). "Metformin monotherapy for adults with type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews 2020 (6 (número de artigo: CD012906)). PMC 7386876. PMID 32501595. doi:10.1002/14651858.CD012906.pub2. (colaboración: Cochrane Metabolic and Endocrine Disorders Group)
Madsen KS, Chi Y, Metzendorf MI, Richter B, Hemmingsen B (decembro de 2019). "Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews 2019 (12 (número de artigo: CD008558)). PMC 6889926. PMID 31794067. doi:10.1002/14651858.CD008558.pub2. (colaboración: Cochrane Metabolic and Endocrine Disorders Group)
Madsen KS, Kähler P, Kähler LK, Madsbad S, Gnesin F, Metzendorf MI, et al. (abril de 2019). Cochrane Metabolic and Endocrine Disorders Group, ed. "Metformin and second- or third-generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews 4 (4 (número de artigo: CD012368)). PMC 6472662. PMID 30998259. doi:10.1002/14651858.CD012368.pub2.
Kulkarni, Amol A.; Sajith, Ayyiliath M.; Duarte, Trevor T.; Tena, Anahis; Spencer, Charles T.; Bowen, J. Phillip (2020). "Design, synthesis, and screening of sulfonylurea-derived NLRP3 inflammasome inhibitors". Medicinal Chemistry Research 29 (1): 126–135. ISSN 1054-2523. PMC 7223447. PMID 32435125. doi:10.1007/s00044-019-02466-7.
Coll RC, Robertson AA, Chae JJ, Higgins SC, Muñoz-Planillo R, Inserra MC, et al. (marzo de 2015). "A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases". Nature Medicine 21 (3): 248–255. PMC 4392179. PMID 25686105. doi:10.1038/nm.3806.
Shyangdan DS, Royle P, Clar C, Sharma P, Waugh N, Snaith A (outubro de 2011). "Glucagon-like peptide analogues for type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews 2011 (10 (número de artigo: CD006423)). PMC 6486297. PMID 21975753. doi:10.1002/14651858.cd006423.pub2.
Hemmingsen B, Schroll JB, Wetterslev J, Gluud C, Vaag A, Sonne DP, et al. (xullo de 2014). "Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysis". CMAJ Open 2 (3): E162–E175. PMC 4185978. PMID 25295236. doi:10.9778/cmajo.20130073.
Hemmingsen B, Schroll JB, Lund SS, Wetterslev J, Gluud C, Vaag A, et al. (abril de 2013). Hemmingsen B, ed. "Sulphonylurea monotherapy for patients with type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews 4 (4 (número de artigo: CD009008)). PMID 23633364. doi:10.1002/14651858.CD009008.pub2. Retractado doi 10.1002/14651858.CD009008.pub3 PMID 26222249 Retraction Watch
Sulfonylureas, Second Generation. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury (Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases). 2012. PMID 31643463. Consultado o 2024-08-16.
Gerstein HC, Miller ME, Byington RP, Goff DC, Bigger JT, Buse JB, et al. (xuño de 2008). "Effects of intensive glucose lowering in type 2 diabetes". The New England Journal of Medicine 358 (24): 2545–2559. PMC 4551392. PMID 18539917. doi:10.1056/NEJMoa0802743.
Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. (xaneiro de 2009). "Glucose control and vascular complications in veterans with type 2 diabetes". The New England Journal of Medicine 360 (2): 129–139. PMID 19092145. doi:10.1056/NEJMoa0808431.
Proks P, Reimann F, Green N, Gribble F, Ashcroft F (decembro de 2002). "Sulfonylurea stimulation of insulin secretion". Diabetes 51 (Suppl 3): S368–S376. PMID 12475777. doi:10.2337/diabetes.51.2007.S368.
Yu, Ming; Feng, Xiao-Yu; Yao, Shuai; Wang, Chang; Yang, Ping (2022-09-16). "Certain sulfonylurea drugs increase serum free fatty acid in diabetic patients: A systematic review and meta-analysis". World Journal of Clinical Cases 10 (26): 9524–9535. ISSN 2307-8960. PMC 9477688. PMID 36159441. doi:10.12998/wjcc.v10.i26.9524.
Zhang CL, Katoh M, Shibasaki T, Minami K, Sunaga Y, Takahashi H, et al. (xullo de 2009). "The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs". Science 325 (5940): 607–610. Bibcode:2009Sci...325..607Z. PMID 19644119. doi:10.1126/science.1172256.
Takahashi T, Shibasaki T, Takahashi H, Sugawara K, Ono A, Inoue N, et al. (outubro de 2013). "Antidiabetic sulfonylureas and cAMP cooperatively activate Epac2A". Science Signaling 6 (298): ra94. PMID 24150255. doi:10.1126/scisignal.2004581. hdl:20.500.14094/D1005987.
Patlak M (decembro de 2002). "New weapons to combat an ancient disease: treating diabetes". FASEB Journal 16 (14): 1853. PMID 12468446. doi:10.1096/fj.02-0974bkt.

pubmed.ncbi.nlm.nih.gov

Hemmingsen B, Schroll JB, Lund SS, Wetterslev J, Gluud C, Vaag A, et al. (abril de 2013). Hemmingsen B, ed. "Sulphonylurea monotherapy for patients with type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews 4 (4 (número de artigo: CD009008)). PMID 23633364. doi:10.1002/14651858.CD009008.pub2. Retractado doi 10.1002/14651858.CD009008.pub3 PMID 26222249 Retraction Watch

orst.edu (Global: low place; Galician: 2,626^th place)

extoxnet.orst.edu

"Nicosulfuron". EXTOXNET. Consultado o 9 de maio de 2013.

retractionwatch.com (Global: low place; Galician: low place)

Hemmingsen B, Schroll JB, Lund SS, Wetterslev J, Gluud C, Vaag A, et al. (abril de 2013). Hemmingsen B, ed. "Sulphonylurea monotherapy for patients with type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews 4 (4 (número de artigo: CD009008)). PMID 23633364. doi:10.1002/14651858.CD009008.pub2. Retractado doi 10.1002/14651858.CD009008.pub3 PMID 26222249 Retraction Watch

web.archive.org (Global: 1^st place; Galician: 1^st place)

"Diaßeta (glyburide) Tablets USP" (PDF). Sanofi-Aventis U.S. LLC. U.S. Food and Drug Administration. 2009. Arquivado dende o orixinal (PDF) o 2 de xaneiro de 2015.

weedscience.org (Global: low place; Galician: low place)

"Classification of Herbicides According to Site of Action". WSSA. 26 de decembro de 2013. Consultado o 16 de agosto de 2025.

worldcat.org (Global: 4^th place; Galician: 7^th place)

Kulkarni, Amol A.; Sajith, Ayyiliath M.; Duarte, Trevor T.; Tena, Anahis; Spencer, Charles T.; Bowen, J. Phillip (2020). "Design, synthesis, and screening of sulfonylurea-derived NLRP3 inflammasome inhibitors". Medicinal Chemistry Research 29 (1): 126–135. ISSN 1054-2523. PMC 7223447. PMID 32435125. doi:10.1007/s00044-019-02466-7.
Yu, Ming; Feng, Xiao-Yu; Yao, Shuai; Wang, Chang; Yang, Ping (2022-09-16). "Certain sulfonylurea drugs increase serum free fatty acid in diabetic patients: A systematic review and meta-analysis". World Journal of Clinical Cases 10 (26): 9524–9535. ISSN 2307-8960. PMC 9477688. PMID 36159441. doi:10.12998/wjcc.v10.i26.9524.

Sulfonilurea (Galician Wikipedia)

adsabs.harvard.edu (Global: 14th place; Galician: 17th place)

aesacademy.org (Global: low place; Galician: low place)

archive.org (Global: 6th place; Galician: 4th place)

books.google.com (Global: 3rd place; Galician: 11th place)

doi.org (Global: 2nd place; Galician: 3rd place)

dx.doi.org

fda.gov (Global: 470th place; Galician: 343rd place)

accessdata.fda.gov

hdl.handle.net (Global: 66th place; Galician: 88th place)

nih.gov (Global: 5th place; Galician: 2nd place)

ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov

orst.edu (Global: low place; Galician: 2,626th place)

extoxnet.orst.edu

retractionwatch.com (Global: low place; Galician: low place)

web.archive.org (Global: 1st place; Galician: 1st place)

weedscience.org (Global: low place; Galician: low place)

worldcat.org (Global: 4th place; Galician: 7th place)

adsabs.harvard.edu (Global: 14^th place; Galician: 17^th place)

archive.org (Global: 6^th place; Galician: 4^th place)

books.google.com (Global: 3^rd place; Galician: 11^th place)

doi.org (Global: 2^nd place; Galician: 3^rd place)

fda.gov (Global: 470^th place; Galician: 343^rd place)

hdl.handle.net (Global: 66^th place; Galician: 88^th place)

nih.gov (Global: 5^th place; Galician: 2^nd place)

orst.edu (Global: low place; Galician: 2,626^th place)

web.archive.org (Global: 1^st place; Galician: 1^st place)

worldcat.org (Global: 4^th place; Galician: 7^th place)